OpenFilings
Theravance Biopharma, Inc.
Form
8-K
Report Period
2025-05-30
Date Filed
2025-06-02
Time Filed
06:02:21
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
FORM 8-K
EXHIBIT 2.1
EXHIBIT 99.1
Filing on SEC Edgar